Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants

Condition:   Parkinson Disease Interventions:   Drug: Tavapadon;   Drug: Carbamazepine Sponsor:   Cerevel Therapeutics, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials